Apixaban Abdi: detailed information

Package leaflet: Information for the user

Apixaban Abdi 2.5 mg film-coated tablets

apixaban
Generic medicine
Please read this leaflet carefully before taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.
If you have any questions, ask your doctor, pharmacist, or nurse.
This medicine has been prescribed for you only. Do not give it to other people, even if they have the same symptoms as yours, because it could be harmful.
If you experience any side effect, including those not listed in this leaflet, contact your doctor, pharmacist, or nurse. See section 4.

Contents of this leaflet

What Apixaban Abdi is and what it is used for
What you need to know before taking Apixaban Abdi
How to take Apixaban Abdi
Possible side effects
How to store Apixaban Abdi
Contents of the pack and other information

1. What Apixaban Abdi is and what it is used for

Apixaban Abdi contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps prevent the formation of blood clots by inhibiting Factor Xa, an important component in blood coagulation.

Apixaban Abdi is used in adults:

to prevent the formation of blood clots (deep vein thrombosis [DVT]) after hip or knee replacement surgery. Following surgery on the hip or knee, you may be at increased risk of developing blood clots in the veins of the legs. This may cause swelling of the legs, with or without pain. If a blood clot travels from the leg to the lungs, it can block blood flow, causing shortness of breath, with or without chest pain. This condition (pulmonary embolism) can be life-threatening and requires immediate medical treatment.
to prevent the formation of blood clots in the heart in patients with irregular heart rhythm (atrial fibrillation) and at least one additional risk factor. Blood clots may break loose and travel to the brain, leading to stroke, or reach other organs, blocking normal blood supply to these organs (also known as systemic embolism). A stroke can be life-threatening and requires immediate medical treatment.
to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), and to prevent recurrence of blood clots in the blood vessels of the legs and/or lungs.

Apixaban Abdi is used in children aged 28 days to less than 18 years to treat blood clots and to prevent recurrence of blood clots in the veins or blood vessels of the lungs.
For the appropriate recommended dose according to body weight, see section 3.

2. What you need to know before taking Apixaban Abdi

Do not take Apixaban Abdi if
you are allergic to apixaban or to any of the other ingredients of this medicine (listed in
section 6);
you have excessive bleeding;
you have a disease in a body organ that increases the risk of serious bleeding
(such as an ulcer, recent or active, in the stomach or intestine, or a recent bleeding in the
brain);
you have a liver disease that increases the risk of bleeding (hepatic coagulopathy);
you are taking medicines to prevent blood clots (e.g., warfarin, rivaroxaban, dabigatran, or heparin), except when switching anticoagulant therapy, while you have a venous or arterial catheter and are receiving heparin through it to keep it open, or if a catheter is inserted into one of your blood vessels (transcatheter ablation) to treat an irregular heartbeat (arrhythmia).

Warnings and precautions
Talk to your doctor, pharmacist, or nurse before taking this medicine if you have any of the following conditions:
an increased risk of bleeding, such as:
bleeding disorders, including conditions leading to reduced platelet function;
very high blood pressure not controlled by medical treatment;
if you are over 75 years old;
if you weigh 60 kg or less;
severe kidney disease or if you are on dialysis;
liver problems or a history of liver problems;
This medicine will be used with caution in patients showing signs of impaired liver function.
you have a tube (catheter) or have had an injection into the spinal column (for anaesthesia or pain relief). Your doctor will advise you to take this medicine at least 5 hours or more after removal of the catheter;
you have a prosthetic heart valve;
if your doctor finds your blood pressure is unstable, or if another treatment or surgical procedure to remove a blood clot from the lungs has been planned.

Use particular caution with Apixaban Abdi
if you know you have a condition called antiphospholipid syndrome (an immune system disorder that increases the risk of blood clots), inform your doctor, who will decide whether a change in therapy is needed.
If you are scheduled for surgery or a procedure that may cause bleeding, your doctor may ask you to temporarily stop taking this medicine for a short period. If you are unsure whether a procedure may cause bleeding, ask your doctor.

Children and adolescents
This medicine is not recommended for children and adolescents with body weight below 35 kg.

Other medicines and Apixaban Abdi
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines.
Some medicines can increase the effect of Apixaban Abdi, while others can reduce it. Your doctor will decide whether you should be treated with Apixaban Abdi when taking these medicines and how closely you need to be monitored.

The following medicines may increase the effect of Apixaban Abdi and increase the risk of unwanted bleeding:
some medicines for fungal infections (e.g., ketoconazole, etc.);
some antiviral medicines for HIV/AIDS (e.g., ritonavir);
other medicines used to reduce blood clotting (e.g., enoxaparin, etc.);
anti-inflammatory drugs or painkillers (e.g., acetylsalicylic acid or naproxen). In particular, if you are over 75 years old and taking acetylsalicylic acid, you may have a higher risk of bleeding;
medicines for high blood pressure or heart problems (e.g., diltiazem);
antidepressants known as selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors.

The following medicines may reduce the effect of Apixaban Abdi in helping to prevent blood clots:
medicines for epilepsy or seizures (e.g., phenytoin, etc.);
St. John’s wort (a herbal remedy used for depression);
medicines to treat tuberculosis or other infections (e.g., rifampicin).

Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, planning to become pregnant, or breastfeeding, consult your doctor, pharmacist, or nurse before taking this medicine.
The effects of Apixaban Abdi on pregnancy and the unborn child are unknown. You must not take this medicine if you are pregnant. Contact your doctor immediately if you become pregnant while taking this medicine.
It is not known whether Apixaban Abdi passes into breast milk. Consult your doctor, pharmacist, or nurse before taking this medicine during breastfeeding. They will advise you whether to stop breastfeeding or to stop or not start treatment with this medicine.

Driving and using machines
Apixaban Abdi has not shown effects on the ability to drive or use machines.

Apixaban Abdi contains lactose (a type of sugar) and sodium
If your doctor has told you that you have an intolerance to certain sugars, contact them before taking this medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, i.e. essentially “sodium-free”.

3. How to take Apixaban Abdi

Take this medicine exactly as instructed by your doctor or pharmacist. If you have
any doubts, consult your doctor, pharmacist, or nurse.
Dosage
Swallow the tablet with a glass of water. Apixaban Abdi can be taken with or without food.
Try to take the tablets at the same time each day to achieve the best effect from
treatment.
If you have difficulty swallowing the whole tablet, ask your doctor about alternative ways Apixaban Abdi can be administered.
The tablet may be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before administration.
Instructions for crushing:
Crush the tablets using a mortar and pestle.
Carefully transfer all the powder into a suitable container, then mix the powder with
a small amount, e.g., 30 mL (2 tablespoons), of water or one of the other liquids mentioned above to prepare a mixture.
Swallow the mixture.
Rinse the mortar and pestle used to crush the tablet and the container with a small amount of water (e.g., 30 mL) or one of the other liquids, and swallow the rinse solution.
If necessary, your doctor may also administer the crushed Apixaban Abdi tablet mixed
with 60 mL of water or 5% glucose in water through a nasogastric tube.
Take Apixaban Abdi as recommended:
To prevent blood clots after hip or knee replacement surgery.
The recommended dose is one Apixaban Abdi 2.5 mg tablet twice daily, for example, one in the morning and one in the evening.
You should take the first tablet 12 to 24 hours after surgery.
If you have undergone major hip surgery, you will usually take the tablets for 32 to 38 days.
If you have undergone major knee surgery, you will usually take the tablets for 10 to 14 days.
To prevent blood clots in the heart in patients with irregular heartbeat and at least one additional risk factor.
The recommended dose is one Apixaban Abdi 5 mg tablet twice daily.
The recommended dose is one Apixaban Abdi 2.5 mg tablet twice daily if:
you have severely reduced kidney function;
you meet two or more of the following criteria:
blood test results suggest poor kidney function (serum creatinine level is 1.5 mg/dL (133 micromoles/L) or higher);
you are 80 years of age or older;
your body weight is 60 kg or less.
The recommended dose is one tablet twice daily, for example, one in the morning and one in the evening.
Your doctor will decide how long you should continue treatment.
To treat blood clots in the veins of the legs and in the blood vessels of the lungs
The recommended dose is two tablets of Apixaban Abdi 5 mg twice daily for the first 7 days, for example, two in the morning and two in the evening.
After 7 days, the recommended dose is one tablet of Apixaban Abdi 5 mg twice daily, for example, one in the morning and one in the evening.
To prevent recurrence of blood clots after completion of 6 months of treatment
The recommended dose is one Apixaban Abdi 2.5 mg tablet twice daily, for example, one in the morning and one in the evening.
Your doctor will decide how long you should continue treatment.
Use in children and adolescents
To treat blood clots and to prevent recurrence of clots in the veins or blood vessels of the lungs.
Take or administer this medicine exactly as instructed by your doctor, the child’s doctor, or pharmacist. If you have any doubts, consult your doctor, the child’s doctor, pharmacist, or nurse.
Try to take or administer the dose at the same time every day to achieve the best effect from treatment.
The dose of Apixaban Abdi depends on body weight and will be calculated by the doctor.
The recommended dose for children and adolescents with body weight of at least 35 kg is four tablets of Apixaban Abdi 2.5 mg twice daily for the first 7 days, for example, four in the morning and four in the evening.
After 7 days, the recommended dose is two tablets of Apixaban Abdi 2.5 mg twice daily, for example, two in the morning and two in the evening.
For parents or caregivers: observe the child to ensure the full dose has been taken.
It is important to attend scheduled medical appointments, as the dose may need to be adjusted as body weight changes.
Your doctor may modify your anticoagulant treatment as follows:
Switching from Apixaban Abdi to another anticoagulant medicine
Stop taking Apixaban Abdi. Start treatment with the anticoagulant medicine (e.g., heparin) at the time you would have taken your next tablet.
Switching from another anticoagulant medicine to Apixaban Abdi
Stop taking the anticoagulant medicine. Start treatment with Apixaban Abdi at the time you would have taken your next dose of the anticoagulant medicine, then continue as usual.
Switching from a vitamin K antagonist anticoagulant treatment (e.g., warfarin) to Apixaban Abdi
Stop taking the vitamin K antagonist medicine. Your doctor will need to perform blood tests and advise you on when to start Apixaban Abdi treatment.
Switching from Apixaban Abdi to a vitamin K antagonist anticoagulant treatment (e.g., warfarin)
If your doctor instructs you to start taking a vitamin K antagonist medicine, continue taking Apixaban Abdi for at least 2 days after the first dose of the vitamin K antagonist medicine. Your doctor will need to perform blood tests and advise you on when to stop Apixaban Abdi treatment.
Patients undergoing cardioversion
If your abnormal heart rhythm needs to be restored to normal by a procedure called cardioversion, take this medicine exactly as your doctor instructs, to prevent blood clots in the blood vessels of the brain and other parts of your body.
If you take more Apixaban Abdi than you should
Contact your doctor immediately if you have taken more than the prescribed dose of this medicine. Bring the medicine packaging with you, even if no tablets remain.
If you take more Apixaban Abdi than recommended, you may have an increased risk of bleeding. If bleeding occurs, surgery, blood transfusion, or other treatments that can reverse the anticoagulant activity against factor Xa may be required.
If you forget to take Apixaban Abdi
If you forget to take your morning dose, take it as soon as you remember, and you may take it together with your evening dose.
A forgotten evening dose may be taken only on the same evening. Do not take two doses the following morning; instead, continue with the twice-daily dosing schedule as recommended the next day.
If you are unsure what to do or if you have missed more than one dose, consult your doctor, pharmacist, or nurse.
If you stop taking Apixaban Abdi
Do not stop taking this medicine without first discussing it with your doctor, as the risk of developing a blood clot may be higher if you stop treatment too early.
If you have any questions about the use of this medicine, consult your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them. Apixaban Abdi may be given for three different medical conditions. The known side effects and their frequency may vary depending on each of these medical conditions and are listed separately below. For these conditions, the most common general side effect with this medicine is bleeding, which can potentially be life-threatening and requires immediate medical attention.

The following side effects are known to occur when Apixaban Abdi is taken to prevent blood clots after hip or knee replacement surgery.

Common side effects (may affect up to 1 in 10 people)
Anaemia, which may cause fatigue or pale skin;
Bleeding, including:
bruising and swelling;
Nausea (feeling unwell).

Uncommon side effects (may affect up to 1 in 100 people)
Reduction in the number of platelets in the blood (which may affect blood clotting);
Bleeding:
occurring after surgery, including bruising and swelling, bleeding or fluid leakage from the surgical wound/incision (wound discharge) or injection site;
from the stomach, intestines, or clear/red blood in faeces;
blood in urine;
from the nose;
from the vagina;
Low blood pressure, which may cause weakness or a rapid heartbeat;
Blood tests may show:
abnormal liver function;
increased levels of certain liver enzymes;
increased bilirubin, a product of red blood cell breakdown, which may cause yellowing of the skin and eyes;
Itching.

Rare side effects (may affect up to 1 in 1,000 people)
Allergic reactions (hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue and/or throat, and difficulty breathing. Contact your doctor immediately if you experience any of these symptoms.
Bleeding:
into the muscle;
into the eyes;
from the gums and blood in sputum when coughing;
from the rectum;
Hair loss.

Not known (frequency cannot be estimated from available data)
Bleeding:
in the brain or spinal cord;
in the lungs or throat;
in the mouth;
in the abdomen or in the space behind the abdominal cavity;
from haemorrhoids;
blood tests showing blood in faeces or urine;
Skin rash that may blister and appear as small spots (dark central spots surrounded by a lighter area, with a dark ring around the edge) (erythema multiforme);
Inflammation of blood vessels (vasculitis), which may present as skin rashes or sharp, flat, red, round spots under the skin surface or bruising.
Bleeding in the kidney, sometimes with blood in the urine, leading to impaired kidney function (anticoagulant-related nephropathy).

The following side effects are known to occur when Apixaban Abdi is taken to prevent blood clots in the heart in patients with irregular heartbeat and at least one additional risk factor.

Common side effects (may affect up to 1 in 10 people)
Bleeding, including:
in the eyes;
in the stomach or intestines;
from the rectum;
blood in urine;
from the nose;
from the gums;
bruising and swelling;
Anaemia, which may cause fatigue or pale skin;
Low blood pressure, which may cause weakness or a rapid heartbeat;
Nausea (feeling unwell);
Blood tests may show:
increased gamma-glutamyl transferase (GGT) levels.

Uncommon side effects (may affect up to 1 in 100 people)
Bleeding:
in the brain or spinal cord;
in the mouth or blood in sputum when coughing;
in the abdomen or from the vagina;
clear/red blood in faeces;
bleeding occurring after surgery, including bruising and swelling, bleeding or fluid leakage from the surgical wound/incision (wound discharge) or injection site;
from haemorrhoids;
blood tests showing blood in faeces or urine;
Reduction in the number of platelets in the blood (which may affect blood clotting);
Blood tests may show:
abnormal liver function;
increased levels of certain liver enzymes;
increased bilirubin, a product of red blood cell breakdown, which may cause yellowing of the skin and eyes;
Skin rash;
Itching;
Hair loss;
Allergic reactions (hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue and/or throat, and difficulty breathing. Contact your doctor immediately if you experience any of these symptoms.

Rare side effects (may affect up to 1 in 1,000 people)
Bleeding:
in the lungs or throat;
in the space behind the abdominal cavity;
into the muscle.

Very rare side effects (may affect up to 1 in 10,000 people)
Skin rash that may blister and appear as small spots (dark central spots surrounded by a lighter area, with a dark ring around the edge) (erythema multiforme).

Not known (frequency cannot be estimated from available data)
Inflammation of blood vessels (vasculitis), which may present as skin rashes or sharp, flat, red, round spots under the skin surface or bruising.
Bleeding in the kidney, sometimes with blood in the urine, leading to impaired kidney function (anticoagulant-related nephropathy).

The following side effects are known to occur when Apixaban Abdi is taken to treat or prevent recurrence of blood clots in the leg veins and blood vessels of the lungs.

Common side effects (may affect up to 1 in 10 people)
Bleeding, including:
from the nose;
from the gums;
blood in urine;
bruising and swelling;
in the stomach, intestines, or from the rectum;
in the mouth;
from the vagina;
Anaemia, which may cause fatigue or pale skin;
Reduction in the number of platelets in the blood (which may affect blood clotting);
Nausea (feeling unwell);
Skin rash;
Blood tests may show:
increased gamma-glutamyl transferase (GGT) or alanine aminotransferase (ALT) levels.

Uncommon side effects (may affect up to 1 in 100 people)
Low blood pressure, which may cause weakness or a rapid heartbeat;
Bleeding:
in the eyes;
in the mouth or blood in sputum when coughing;
clear/red blood in faeces;
blood tests showing blood in faeces or urine;
bleeding occurring after surgery, including bruising and swelling, bleeding or fluid leakage from the surgical wound/incision (wound discharge) or injection site;
from haemorrhoids;
into the muscle;
Itching;
Hair loss;
Allergic reactions (hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue and/or throat, and difficulty breathing. Contact your doctor immediately if you experience any of these symptoms.
Blood tests may show:
abnormal liver function;
increased levels of certain liver enzymes;
increased bilirubin, a product of red blood cell breakdown, which may cause yellowing of the skin and eyes.

Rare side effects (may affect up to 1 in 1,000 people)
Bleeding:
in the brain or spinal cord;
in the lungs.

Not known (frequency cannot be estimated from available data)
Bleeding:
in the abdomen or in the space behind the abdominal cavity.
Skin rash that may blister and appear as small spots (dark central spots surrounded by a lighter area, with a dark ring around the edge) (erythema multiforme);
Inflammation of blood vessels (vasculitis), which may present as skin rashes or sharp, flat, red, round spots under the skin surface or bruising.
Bleeding in the kidney, sometimes with blood in the urine, leading to impaired kidney function (anticoagulant-related nephropathy).

Other side effects in children and adolescents
Contact the child’s doctor immediately if you notice any of these symptoms:
Allergic reactions (hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue and/or throat, and difficulty breathing. The frequency of these side effects is common (may affect up to 1 in 10 people).

In general, the side effects observed in children and adolescents treated with Apixaban Abdi have been similar in type to those observed in adults and have mainly been mild to moderate in severity. The side effects observed more frequently in children and adolescents have been nosebleeds and abnormal vaginal bleeding.

Very common side effects (may affect more than 1 in 10 people)
Bleeding, including:
from the vagina;
from the nose.

Common side effects (may affect up to 1 in 10 people)
Bleeding, including:
from the gums;
blood in urine;
bruising and swelling;
from the intestines or rectum;
clear/red blood in faeces;
bleeding occurring after any surgery, including bruising and swelling, bleeding or fluid leakage from the surgical wound/incision (wound discharge) or injection site;
Hair loss;
Anaemia, which may cause fatigue or pale skin;
Reduction in the number of platelets in the child’s blood (which may affect blood clotting);
Nausea (feeling unwell);
Skin rash;
Itching;
Low blood pressure, which may cause the child weakness or a rapid heartbeat;
Blood tests may show:
abnormal liver function;
increased levels of certain liver enzymes;
increased alanine aminotransferase (ALT).

Not known (frequency cannot be estimated from available data)
Bleeding:
in the abdomen or in the space behind the abdominal cavity;
in the stomach;
in the eyes;
in the mouth;
from haemorrhoids;
in the mouth or blood in sputum when coughing;
in the brain or spinal cord;
in the lungs;
into the muscle;
Skin rash that may blister and appear as small spots (dark central spots surrounded by a lighter area, with a dark ring around the edge) (erythema multiforme);
Inflammation of blood vessels (vasculitis), which may present as skin rashes or sharp, flat, red, round spots under the skin surface or bruising;
Blood tests may show:
increased gamma-glutamyl transferase (GGT);
blood tests showing blood in faeces or urine.
Bleeding in the kidney, sometimes with blood in the urine, leading to impaired kidney function (anticoagulant-related nephropathy).

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, please contact your doctor, pharmacist, or nurse. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
Reporting side effects can help provide more information on the safety of this medicine.

5. How to store Apixaban Abdi

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after Exp. or EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Apixaban Abdi contains

The active substance is apixaban. Each tablet contains 2.5 mg of apixaban.
The other components are: Tablet core: lactose (see section 2 "Apixaban Abdi contains lactose (a type of sugar) and sodium"), microcrystalline cellulose, sodium croscarmellose (see section 2 "Apixaban Abdi contains lactose (a type of sugar) and sodium"), sodium lauryl sulfate, magnesium stearate (E470b); Coating: monohydrate lactose (see section 2 "Apixaban Abdi contains lactose (a type of sugar) and sodium"), HPMC 2910/hypromellose (E464), titanium dioxide (E171), triacetin, yellow iron oxide (E172).

Description of the appearance of Apixaban Abdi and contents of the pack
(film-coated tablet)
Yellow, round, biconvex tablet, with "A1" engraved on one side and smooth on the other. It is available in
PVC/PE/PVDC-aluminum blisters containing 20, 60, and 200 film-coated tablets.
Not all pack sizes may be marketed.

Patient Alert Card: managing information
Inside the Apixaban Abdi package, together with the package leaflet, you will find a Patient Alert Card or your doctor may have given you a similar one.
This Patient Alert Card includes information that may be useful to you and alerts other doctors that you are taking Apixaban Abdi. You must always keep this card with you.

Take the card.
Tear off the text in your language as needed (this will be facilitated by the pre-perforated edge).
Complete the following sections or ask your doctor to do so: Name: Date of birth: Indication: Dose: ......mg twice daily Physician's name: Physician's telephone number:
Fold the card and always keep it with you.

Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Abdi Farma GmbH
Donnersbergstraße 4
64646 Heppenheim
Germany
Manufacturer
Interpharma Services Ltd.
43A Cherni Vrach Blvd.
1407 Sofia
Bulgaria
Flavine Pharma France
3 Voie d'Allemagne
13127 Vitrolles
France
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park,
Paola, Malta
PLA3000

Package leaflet: Information for the user

Apixaban Abdi 5 mg film-coated tablets

apixaban
Generic medicine
Please read this leaflet carefully before taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.
If you have any questions, ask your doctor, pharmacist, or nurse.
This medicine has been prescribed for you only. Do not give it to others, even if their symptoms are the same as yours, as it could be harmful.
If you experience any adverse reactions, including those not listed in this leaflet, contact your doctor, pharmacist, or nurse. See section 4.

Contents of this leaflet

What Apixaban Abdi is and what it is used for
What you need to know before taking Apixaban Abdi
How to take Apixaban Abdi
Possible side effects
How to store Apixaban Abdi
Package contents and other information

1. What Apixaban Abdi is and what it is used for

Apixaban Abdi contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps prevent the formation of blood clots by blocking Factor Xa, an important component in blood coagulation.

Apixaban Abdi is used in adults:

to prevent the formation of blood clots in the heart in patients with irregular heartbeat (atrial fibrillation) and with at least one additional risk factor. Blood clots may break loose, travel to the brain and cause stroke, or reach other organs and block normal blood flow to these organs (also known as systemic embolism). A stroke can be life-threatening and requires immediate medical treatment.
to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), and to prevent the recurrence of blood clots in the blood vessels of the legs and/or lungs.

Apixaban Abdi is used in children aged 28 days to less than 18 years to treat blood clots and to prevent the recurrence of blood clots in veins or blood vessels of the lungs.
For the recommended dose according to body weight, see section 3.

2. What you need to know before taking Apixaban Abdi

Do not take Apixaban Abdi if
you are allergic to apixaban or to any of the other ingredients of this medicine (listed in
section 6);
you have excessive bleeding;
you have a disease in an organ of the body that leads to an increased risk of serious bleeding
(such as a stomach or intestinal ulcer, recent or active, or recent bleeding in the brain);
you have a liver disease that increases the risk of bleeding (hepatic coagulopathy);
you are taking medicines to prevent blood clots (e.g., warfarin, rivaroxaban, dabigatran or heparin), except when switching anticoagulant therapy, while having a venous or arterial catheter and receiving heparin through it to keep it open, or if a catheter is inserted into a blood vessel (transcatheter ablation) to treat an irregular heartbeat (arrhythmia).

Warnings and precautions
Talk to your doctor, pharmacist or nurse before taking this medicine if you have any of the following conditions:
an increased risk of bleeding, such as:
bleeding disorders, including conditions leading to reduced platelet function;
very high blood pressure not controlled by medical treatment;
if you are over 75 years of age;
if you weigh 60 kg or less;
severe kidney disease or if you are on dialysis;
liver problems or a history of liver problems;
This medicine will be used with caution in patients showing signs of impaired liver function.
you have had a tube (catheter) or an injection in the spine (for anaesthesia or pain relief), your doctor will instruct you to take this medicine 5 hours or more after removal of the catheter;
you have a prosthetic heart valve;
your doctor finds that your blood pressure is unstable or if another treatment or surgical procedure to remove a blood clot from the lungs has been planned.

Take special care with Apixaban Abdi
if you know you have a condition called antiphospholipid syndrome (an immune system disorder that increases the risk of blood clots), inform your doctor, who will decide whether a change in therapy is needed.

If you are scheduled for surgery or a procedure that may cause bleeding, your doctor may ask you to temporarily stop taking this medicine for a short period. If you are unsure whether a procedure might cause bleeding, ask your doctor.

Children and adolescents
This medicine is not recommended for children and adolescents weighing less than 35 kg.

Other medicines and Apixaban Abdi
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.

Some medicines can increase the effect of Apixaban Abdi, while others can reduce it. Your doctor will decide whether you should be treated with Apixaban Abdi when taking these medicines and how closely you should be monitored.

The following medicines may increase the effect of Apixaban Abdi and increase the risk of unwanted bleeding:
some medicines for fungal infections (e.g., ketoconazole, etc.);
some antiviral medicines for HIV/AIDS (e.g., ritonavir);
other medicines used to reduce blood clotting (e.g., enoxaparin, etc.);
anti-inflammatory drugs or painkillers (e.g., acetylsalicylic acid or naproxen). In particular, if you are over 75 years of age and taking acetylsalicylic acid, your risk of bleeding may be higher;
medicines for high blood pressure or heart problems (e.g., diltiazem);
antidepressants known as selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors.

Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant or are planning to become pregnant, or if you are breastfeeding, consult your doctor, pharmacist or nurse before taking this medicine.

The effects of Apixaban Abdi on pregnancy and the unborn child are unknown. You must not take this medicine if you are pregnant. Contact your doctor immediately if you become pregnant while taking this medicine.

It is not known whether Apixaban Abdi passes into breast milk. Consult your doctor, pharmacist or nurse before taking this medicine during breastfeeding. They will advise you whether to discontinue breastfeeding or to discontinue/avoid starting treatment with this medicine.

Driving and using machines
Apixaban Abdi has not shown effects on the ability to drive vehicles or operate machinery.

Apixaban Abdi contains lactose (a type of sugar) and sodium
If your doctor has told you that you have an intolerance to certain sugars, contact them before taking this medicine.

This medicine contains less than 1 mmol (23 mg) of sodium per tablet, i.e., essentially “sodium-free”.

3. How to take Apixaban Abdi

Take this medicine exactly as instructed by your doctor or pharmacist. If you have
any doubts, consult your doctor, pharmacist, or nurse.
Dose
Swallow the tablet with a little water. Apixaban Abdi may be taken with or without food.
Try to take the tablets at the same time each day to achieve the best effect from
treatment.
If you have difficulty swallowing the tablet whole, ask your doctor about alternative ways Apixaban Abdi can be administered.
The tablet can be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before taking.
Instructions for crushing:
Crush the tablets with a mortar and pestle.
Carefully transfer all of the powder into a suitable container and then mix the powder with
a small amount, e.g., 30 mL (2 tablespoons), of water or one of the other liquids mentioned above to prepare a mixture.
Swallow the mixture.
Rinse the mortar and pestle used to crush the tablet and the container with a small amount of water (e.g., 30 mL) or one of the other liquids, and swallow the rinse.
If necessary, your doctor may also administer the crushed Apixaban Abdi tablet mixed with 60 mL of water or 5% glucose in water through a nasogastric tube.
Take Apixaban Abdi as recommended:
To prevent the formation of blood clots in the heart in patients with irregular heartbeat and
at least one additional risk factor.
The recommended dose is one Apixaban Abdi 5 mg tablet twice daily.
The recommended dose is one Apixaban Abdi 2.5 mg tablet twice daily if:
you have severely reduced kidney function;
you meet two or more of the following criteria:
blood test results suggest poor kidney function (serum creatinine level is 1.5 mg/dL (133 micromoles/L) or higher);
you are 80 years of age or older;
your body weight is 60 kg or less.
The recommended dose is one tablet twice daily, for example, one in the morning and one in the evening.
Your doctor will decide how long you should continue treatment.
For treating blood clots in the veins of the legs and in the blood vessels of the lungs
The recommended dose is two tablets of Apixaban Abdi 5 mg twice daily for the first 7 days,
for example, two in the morning and two in the evening.
After 7 days, the recommended dose is one tablet of Apixaban Abdi 5 mg twice daily, for
example, one in the morning and one in the evening.
To prevent recurrence of blood clots after completing 6 months of treatment
The recommended dose is one tablet of Apixaban Abdi 2.5 mg twice daily, for example, one in
the morning and one in the evening.
Your doctor will decide how long you should continue treatment.
Use in children and adolescents
For treating blood clots and preventing recurrence of blood clots in veins or blood vessels of the lungs.
Take or administer this medicine exactly as instructed by your doctor or the child's doctor or pharmacist. If you have any doubts, consult your doctor or the child's doctor, pharmacist, or nurse.
Try to take or administer the dose at the same time each day to achieve the best effect from treatment.
The dose of Apixaban Abdi depends on body weight and will be calculated by the doctor.
The recommended dose for children and adolescents with body weight of at least 35 kg is two
tablets of Apixaban Abdi 5 mg twice daily for the first 7 days, for example, two in the morning and
two in the evening.
After 7 days, the recommended dose is one tablet of Apixaban Abdi 5 mg twice daily, for
example, one in the morning and one in the evening.
For parents or caregivers: observe the child to ensure they have taken the full dose.
It is important to keep scheduled medical appointments, as the dose may need to be adjusted as body weight changes.
Your doctor may adjust your anticoagulant treatment as follows:
Switching from Apixaban Abdi to another anticoagulant medicine
Stop taking Apixaban Abdi. Start treatment with the anticoagulant medicine (e.g., heparin) at the time you would have taken your next tablet.
Switching from another anticoagulant medicine to Apixaban Abdi
Stop taking the anticoagulant medicine. Start treatment with Apixaban Abdi at the time you would have taken your next dose of the anticoagulant medicine, then continue taking it as usual.
Switching from treatment with a vitamin K antagonist anticoagulant (e.g., warfarin) to Apixaban Abdi
Stop taking the vitamin K antagonist medicine. Your doctor will need to perform blood tests and advise you when to start treatment with Apixaban Abdi.
Switching from Apixaban Abdi to treatment with a vitamin K antagonist anticoagulant (e.g., warfarin)
If your doctor instructs you to start taking a medicine containing a vitamin K antagonist, continue taking Apixaban Abdi for at least 2 days after the first dose of the vitamin K antagonist medicine. Your doctor will need to perform blood tests and advise you when to stop treatment with Apixaban Abdi.
Patients undergoing cardioversion
If your abnormal heartbeat needs to be restored to normal by a procedure called cardioversion, take this medicine exactly as your doctor instructs, to prevent blood clots in blood vessels in the brain and other parts of your body.
If you take more Apixaban Abdi than you should
Contact your doctor immediately if you have taken more than the prescribed dose of Apixaban Abdi. Bring the medicine pack with you, even if no tablets remain.
If you take more Apixaban Abdi than recommended, you may have an increased risk of bleeding. If bleeding occurs, you may require surgery, a blood transfusion, or other treatments that can reverse the anticoagulant activity against factor Xa.
If you forget to take Apixaban Abdi
If you forget to take a morning dose, take it as soon as you remember, and you may take it together with your evening dose.
A forgotten evening dose may be taken only on the same evening. Do not take two doses the following morning; instead, continue with the twice-daily dosing schedule as recommended the next day.
If you are unsure what to do or if you have missed more than one dose, consult your doctor, pharmacist, or nurse.
If you stop taking Apixaban Abdi
Do not stop taking this medicine without first talking to your doctor, as the risk of developing a blood clot may be higher if you stop treatment too early.
If you have any questions about how to use this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them. The most common general side effect of this medicine is bleeding, which may potentially be life-threatening and requires immediate medical attention.

The following side effects are known to occur when Apixaban Abdi is taken to prevent blood clots forming in the heart in patients with irregular heartbeat and at least one additional risk factor.

Common side effects (may affect up to 1 in 10 people)
Bleeding, including:
in the eyes;
in the stomach or intestines;
from the rectum;
blood in the urine;
from the nose;
from the gums;
bruising and swelling;
Anaemia, which may cause tiredness or pale skin;
Low blood pressure, which may cause weakness or a rapid heartbeat;
Nausea (feeling unwell);
Blood tests may show:
an increase in gamma-glutamyl transferase (GGT).

Uncommon side effects (may affect up to 1 in 100 people)
Bleeding:
in the brain or spinal cord;
in the mouth or blood in coughed-up mucus;
in the abdomen or from the vagina;
bright red blood in the stools;
bleeding after surgery, including bruising and swelling, leakage of blood or fluid from the surgical wound/incision (wound discharge) or from the injection site;
from haemorrhoids;
tests showing blood in the stools or urine;
Reduction in the number of platelets in the blood (which may affect blood clotting);
Blood tests may show:
abnormal liver function;
increase in certain liver enzymes;
increase in bilirubin, a product of red blood cell breakdown, which may cause yellowing of the skin and eyes;
Skin rash;
Itching;
Hair loss;
Allergic reactions (hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue and/or throat and difficulty breathing. Contact your doctor immediately if you experience any of these symptoms.

Rare side effects (may affect up to 1 in 1,000 people)
Bleeding:
in the lungs or throat;
in the space behind the abdominal cavity (retroperitoneal space);
in the muscle.

Very rare side effects (may affect up to 1 in 10,000 people)
Skin rash which may blister and appears as small spots (dark central spots surrounded by a lighter area, with a dark ring around the edge) (erythema multiforme).

Not known (frequency cannot be estimated from the available data)
Inflammation of blood vessels (vasculitis), which may present as skin rashes or small, flat, red, round spots or bruises under the skin surface.
Bleeding in the kidney, sometimes with blood in the urine, leading to impaired kidney function (anticoagulant-related nephropathy).

The following side effects are known to occur when Apixaban Abdi is taken to treat or prevent recurrence of blood clots in the veins of the legs and in the blood vessels of the lungs.

Common side effects (may affect up to 1 in 10 people)
Bleeding, including:
from the nose;
from the gums;
blood in the urine;
bruising and swelling;
in the stomach, intestines, or from the rectum;
in the mouth;
from the vagina;
Anaemia, which may cause tiredness or pale skin;
Reduction in the number of platelets in the blood (which may affect blood clotting);
Nausea (feeling unwell);
Skin rash;
Blood tests may show:
an increase in gamma-glutamyl transferase (GGT) or alanine aminotransferase (ALT).

Uncommon side effects (may affect up to 1 in 100 people)
Low blood pressure, which may cause weakness or a rapid heartbeat;
Bleeding:
in the eyes;
in the mouth or blood in coughed-up mucus;
bright red blood in the stools;
tests showing blood in the stools or urine;
bleeding after any surgery, including bruising and swelling, leakage of blood or fluid from the surgical wound/incision (wound discharge) or from the injection site;
from haemorrhoids;
in the muscle;
Itching;
Hair loss;
Allergic reactions (hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue and/or throat and difficulty breathing. Contact your doctor immediately if you experience any of these symptoms.
Blood tests may show:
abnormal liver function;
increase in certain liver enzymes;
increase in bilirubin, a product of red blood cell breakdown, which may cause yellowing of the skin and eyes.

Rare side effects (may affect up to 1 in 1,000 people)
Bleeding:
in the brain or spinal cord;
in the lungs.

Not known (frequency cannot be estimated from the available data)
Bleeding:
in the abdomen or in the space behind the abdominal cavity (retroperitoneal space).
Skin rash which may blister and appears as small spots (dark central spots surrounded by a lighter area, with a dark ring around the edge) (erythema multiforme);
Inflammation of blood vessels (vasculitis), which may present as skin rashes or small, flat, red, round spots or bruises under the skin surface.
Bleeding in the kidney, sometimes with blood in the urine, leading to impaired kidney function (anticoagulant-related nephropathy).

Other side effects in children and adolescents
Contact the child’s doctor immediately if you notice any of these symptoms:
Allergic reactions (hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue and/or throat and difficulty breathing. The frequency of these side effects is common (may affect up to 1 in 10 people).

In general, the side effects observed in children and adolescents treated with Apixaban Abdi have been similar to those seen in adults and have mainly been mild to moderate in severity. The side effects observed more frequently in children and adolescents were nosebleeds and abnormal vaginal bleeding.

Very common side effects (may affect more than 1 in 10 people)
Bleeding, including:
from the vagina;
from the nose.

Common side effects (may affect up to 1 in 10 people)
Bleeding, including:
from the gums;
blood in the urine;
bruising and swelling;
from the intestine or rectum;
bright red blood in the stools;
bleeding after any surgery, including bruising and swelling, leakage of blood or fluid from the surgical wound/incision (wound discharge) or from the injection site;
Hair loss;
Anaemia, which may cause tiredness or pale skin;
Reduction in the number of platelets in the child’s blood (which may affect blood clotting);
Nausea (feeling unwell);
Skin rash;
Itching;
Low blood pressure, which may cause the child to feel weak or have a rapid heartbeat;
Blood tests may show:
abnormal liver function;
increase in certain liver enzymes;
increase in alanine aminotransferase (ALT).

Not known (frequency cannot be estimated from the available data)
Bleeding:
in the abdomen or in the space behind the abdominal cavity (retroperitoneal space);
in the stomach;
in the eyes;
in the mouth;
from haemorrhoids;
in the mouth or blood in coughed-up mucus;
in the brain or spinal cord;
in the lungs;
in the muscle;
Skin rash which may blister and appears as small spots (dark central spots surrounded by a lighter area, with a dark ring around the edge) (erythema multiforme);
Inflammation of blood vessels (vasculitis), which may present as skin rashes or small, flat, red, round spots or bruises under the skin surface;
Blood tests may show:
an increase in gamma-glutamyl transferase (GGT);
tests showing blood in the stools or urine.
Bleeding in the kidney, sometimes with blood in the urine, leading to impaired kidney function (anticoagulant-related nephropathy).

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor, pharmacist, or nurse. You can also report side effects directly via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Apixaban Abdi

6. Package contents and other information

What Apixaban Abdi contains

The active substance is apixaban. Each tablet contains 5 mg of apixaban.
The other components are:
Tablet core: lactose (see section 2 "Apixaban Abdi contains lactose (a type of sugar) and sodium"), microcrystalline cellulose, sodium croscarmellose (see section 2 "Apixaban Abdi contains lactose (a type of sugar) and sodium"), sodium lauryl sulfate, magnesium stearate (E470b);
Coating: monohydrate lactose (see section 2 "Apixaban Abdi contains lactose (a type of sugar) and sodium"), hypromellose (E464), titanium dioxide (E171), triacetin, red iron oxide (E172).

Description of the appearance of Apixaban Abdi and contents of the pack
(film-coated tablet)
Pink, oval, biconvex tablet, film-coated, with "A2" engraved on one side and smooth on the other. Available in PVC/PE/PVDC-aluminum blisters containing 20, 60, and 200 film-coated tablets.
Not all pack sizes may be marketed.

Patient Alert Card: managing information
Inside the Apixaban Abdi package, together with the package leaflet, you will find a Patient Alert Card, or your doctor may have given you a similar one.
This Patient Alert Card includes important information that may be useful to you and alerts other healthcare professionals that you are taking Apixaban Abdi. You must always carry this card with you.

Take the card.
Tear off the text in your language as needed (this will be facilitated by the pre-perforated edge).
Complete the following sections, or ask your doctor to do so:
Name:
Date of birth:
Indication:
Dose: mg twice daily
Name of doctor:
Doctor’s telephone number:
Fold the card and always keep it with you.